| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.911 | 22.966 | 27.845 | 43.089 | 48.401 | 64.561 | 82.338 |
| Total Income - EUR | - | - | - | 4.911 | 22.966 | 27.845 | 43.089 | 48.401 | 64.561 | 82.338 |
| Total Expenses - EUR | - | - | - | 119 | 460 | 731 | 5.344 | 12.276 | 11.553 | 19.968 |
| Gross Profit/Loss - EUR | - | - | - | 4.792 | 22.506 | 27.113 | 37.745 | 36.125 | 53.008 | 62.370 |
| Net Profit/Loss - EUR | - | - | - | 4.644 | 21.817 | 26.337 | 36.958 | 35.640 | 52.363 | 59.900 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Neuro Clinique Diacenco S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 26 | 0 | 605 | 591 | 2.621 | 592 | 915 |
| Current Assets | - | - | - | 4.958 | 27.684 | 53.114 | 89.908 | 65.946 | 81.334 | 63.701 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 2.738 | 0 | 0 |
| Receivables | - | - | - | 537 | 1.358 | 0 | 853 | 26.257 | 1.200 | 1.548 |
| Cash | - | - | - | 4.421 | 26.326 | 53.114 | 89.055 | 36.952 | 80.134 | 62.153 |
| Shareholders Funds | - | - | - | 4.687 | 26.414 | 52.250 | 88.049 | 36.565 | 53.165 | 62.509 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 297 | 1.270 | 1.469 | 2.451 | 32.002 | 28.761 | 2.107 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro Clinique Diacenco S.r.l.